Laredo Medical Center ER Offers Monoclonal Antibody Infusion Therapy

8/2/2021

Laredo Medical Center ER is offering monoclonal antibody therapies for treating patients with mild or moderate COVID-19 symptoms. This one-time ER infusion therapy may help patients recover quicker and avoid hospitalization. This treatment is especially useful for patients with conditions that put them at higher risk of developing a more severe form of the disease.

If you have recently tested positive for COVID-19, visit one of our emergency departments, which are open 24 hours, 7 days a week.

Monoclonal antibody therapy is approved for certain patients who:

• Have positive results of direct SARS-CoV-2 viral testing;
• Are experiencing mild to moderate COVID-19 symptoms, and
• Are at high-risk for COVID-19 symptoms progressing to severe levels.

High risk is defined as patients who meet at least one of the following criteria in addition to meeting the previous criteria:

• Are 65 years or older
• Have a body mass index (BMI) of 35 or higher
• Have diabetes, chronic kidney disease, or a immunosuppressive disease
• Are currently taking immunosuppressive medication
• Are 55 years or older and have heart disease, hypertension (high blood pressure), or a chronic respiratory disease.

Laredo Medical Center ER & Laredo Medical Center-North Central ER are administering this one-time treatment after evaluation by one of our ER physicians.

For more information, visit www.laredomedical.com/emergency-department.

### Back